ArticleJournal of hepatocellular carcinoma2025
Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China.
Qiuwen Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.